Mannatech (NASDAQ:MTEX) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX) in a research report released on Monday morning. The brokerage issued a buy rating on the stock.

Mannatech Trading Up 4.3 %

NASDAQ:MTEX opened at $8.40 on Monday. The stock has a market cap of $15.79 million, a P/E ratio of -10.37 and a beta of 1.17. Mannatech has a 1 year low of $6.75 and a 1 year high of $10.51. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.74 and a current ratio of 1.25. The stock has a 50-day simple moving average of $7.79 and a 200-day simple moving average of $7.54.

Mannatech (NASDAQ:MTEX) last announced its earnings results on Tuesday, November 12th. The company reported ($0.17) earnings per share (EPS) for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%. The business had revenue of $31.73 million for the quarter.

Insider Buying and Selling

In other news, Director Larry A. Jobe sold 16,288 shares of the business’s stock in a transaction on Monday, September 9th. The stock was sold at an average price of $7.75, for a total value of $126,232.00. Following the completion of the transaction, the director now directly owns 54,721 shares of the company’s stock, valued at $424,087.75. The trade was a 22.94 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 41.50% of the stock is owned by insiders.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.